The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

Valued at $50 billion, the Indian pharmaceutical sector continues to grow, fueled by cost efficiency, cutting-edge ...

Venus Remedies receives marketing authorisation for Sugammadex in the Philippines, marking a major step in its expansion into complex generics and the ASEAN market. Sugammadex is a relaxant-binding ...

A Senate committee this week will almost surely push forward the FDA and NIH nominees. Neither one has the public interest at ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, ...

The higher prices of two COPD inhalers from GSK that are targeted in the second round of government drug price negotiations ...

Venus Remedies receives marketing authorization for Sugammadex from Philippines: Our Bureau, Mumbai Tuesday, March 4, 2025, 15:40 Hrs [IST] Venus Remedies Limited, a leading India ...

The basket acquired, comprises of 13 ANDAs, which are approved by the US Food anf Drugs Administration (US FDA) and 1 ANDA, ...

Kenneth Andrade is known for taking high-conviction calls, backing them with sizeable allocation in his portfolio. So where ...

Financially, Monopar has a cash runway until 2026 but will need additional funds for commercialization efforts. See why I'm ...

Known as one of Vietnam’s most notable new-generation trade deals, the EU-Vietnam Free Trade Agreement (EVFTA) marks a ...